FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary
Clinical trial NCT05263700 · UNKNOWN
Trial details
- NCT number
- NCT05263700
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-23
- Primary completion
- 2024-02-22
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.